ASHLEY NANNEY: Open Payments
NPI 1205532215 · NEW ALBANY, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$96 in 6 payments from 4 companies in 2025. Trend: 2023 $106 · 2024 $85 · 2025 $96
Food & beverage: $96
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $45 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| ABBVIE INC. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: VAXNEUVANCE, QULIPTA, BEXSERO, Qelbree, PENMENVY, SHINGRIX.
Industry payments across MS — which companies pay providers there.
